Reliability of Multiple-Repetition-Maximum Tests in Patients with Cardiovascular Disease or Risk Factors
Launched by TECHNICAL UNIVERSITY OF MUNICH · Jan 22, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how reliable different tests are for measuring strength in patients with heart-related issues, like heart failure, coronary heart disease, or diabetes. Specifically, the study will compare two methods of estimating how much weight a person can lift at their maximum, using tests that are safer for people who may not have experience with heavy lifting. The goal is to find out if these methods work well for people with cardiovascular conditions, which can help guide their exercise training safely.
To participate in this study, individuals must be at least 50 years old and have one or more specific heart-related conditions or risk factors, such as heart failure or high blood pressure. They should also be stable in their health for at least four weeks and have permission from their doctor to engage in strength training. Participants can expect to undergo strength tests that help researchers understand how effectively they can lift weights. It’s important to note that those with certain medical issues, like severe joint pain or uncontrolled high blood pressure, will not be eligible for the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 50 years
- * At least one of the following cardiovascular diseases / risk factors:
- • Heart failure
- • Coronary heart disease
- • Atrial fibrillation
- • Arterial hypertension
- • Type 2 diabetes mellitus
- • Clinically stable for ≥ 4 weeks
- • Medical clearance to perform resistance training / strength testing
- • Signed written informed consent
- Exclusion Criteria:
- • Pregnancy
- • Acute infection
- • Chronic joint inflammation
- • Knee, hip, ankle, wrist, elbow or shoulder pain
- • Known osteoporosis (T-value ≤ -2.5)
- • Uncontrolled hypertension (≥160 mmHG systolic / ≥100 mmHG diastolic)
- • Known cerebral or thoracic aneurysm
About Technical University Of Munich
The Technical University of Munich (TUM) is a leading research institution in Germany, renowned for its commitment to excellence in education, innovation, and technology transfer. With a strong emphasis on interdisciplinary collaboration, TUM fosters advancements in various fields, including medicine and life sciences. The university actively engages in clinical research, aiming to translate scientific discoveries into practical applications that improve patient outcomes. Through its state-of-the-art facilities and a network of partnerships with hospitals and industry, TUM is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and contribute significantly to the advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Stephan Mueller, Dr rer nat
Principal Investigator
Technical University of Munich, Department for Preventive Sports Medicine and Sports Cardiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported